# Inhaled Ciclesonide Study in Preterm Infants

> **NCT06589245** · PHASE1 · RECRUITING · sponsor: **Venkatesh Sampath** · enrollment: 30 (estimated)

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** Alvesco Inhalant Product

## Key facts

- **NCT ID:** NCT06589245
- **Lead sponsor:** Venkatesh Sampath
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-16
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06589245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06589245, "Inhaled Ciclesonide Study in Preterm Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06589245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*